Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026

Detailed price information for Kyverna Therapeutics Inc (KYTX-Q) from The Globe and Mail including charting and trades.

BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting

BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced the acceptance of ...

TeleSpecialists Pilot Mentorship Program Sends Two Research Interns to Present at World's Largest Neurology Conference

TeleSpecialists, the nation's largest dedicated teleneurology company, announced today that its pilot research mentorship program has produced two poster presentations at the 2026 American Academy of ...
Medscape

Relapsing-Remitting Multiple Sclerosis

Insights from AAN 2026, including anticipated presentations, key takeaways, and how emerging research in RRMS may affect ...
Medscape

Conference MDAngle: AAN 2025

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients. Dr ...

SK Biopharmaceuticals to Present Key Cenobamate Data at American Academy of Neurology Meeting

SK Biopharmaceuticals’ US subsidiary, SK Life Science, announced that it will present multiple posters at the 2026 American Academy of Neurology ...